Search results
Older adults with aggressive blood cancer are responsive to treatment and show prolonged survival:...
Medical Xpress· 15 hours agoStandard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults over...
Researchers discover new target for potential leukemia therapy
Medical Xpress· 2 days agoThe study provides both mechanistic and preclinical evidence supporting the rapid initiation of...
Leukemia Therapeutics Market Expected to Grow at USD 13491.42 Million by 2030: SNS Insider
Digital Journal· 6 days agoThe global leukemia therapeutics market has witnessed significant growth in recent years, driven by...
GlycoMimetics Shares Drop After Leukemia Treatment Trial Fails to Meet Primary Endpoint
Market Watch· 4 days agoBy Adriano Marchese GlycoMimetics shares were sharply lower in premarket trading on Monday after the company said its drug to treat a form of acute myeloid...
GlycoMimetics reports Phase 3 trial of uproleselan falls short By Investing.com
Investing.com· 3 days agoThe study aimed to determine the efficacy of uproleselan in improving survival rates when used...
Red carpet with a cause: This fashion show fundraiser helps kids with cancer
The Bergen Record via Yahoo News· 21 hours ago“He’s really happy and very thankful for everyone who helped him,” Peña said. Most proceeds from...
Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and...
WTNH-TV New Haven· 2 days agoSyndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an...
Apollomics shares target cut on Phase 3 study results By Investing.com
Investing.com· 1 day agoThe adjustment came in response to recently revealed Phase 3 study results which did not meet the...
Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin
NBC 17 Raleigh· 16 hours agoMoleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses ...
2 Incredible Growth Stocks to Buy Hand Over Fist
Motley Fool via Yahoo Finance· 2 days agoThis novel oral treatment for leukemia has the potential to surpass $1 billion in sales if it secures regulatory nods in both the front- and later-line...